The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-N-(3,5-Dichlorophenyl)-4-(6-oxo-1,6-dihydropyridin-3-yl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxamide ID: ALA4551301
PubChem CID: 155555227
Max Phase: Preclinical
Molecular Formula: C19H15Cl2N3O2S
Molecular Weight: 420.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cc(Cl)cc(Cl)c1)N1CCc2sccc2C1c1ccc(=O)[nH]c1
Standard InChI: InChI=1S/C19H15Cl2N3O2S/c20-12-7-13(21)9-14(8-12)23-19(26)24-5-3-16-15(4-6-27-16)18(24)11-1-2-17(25)22-10-11/h1-2,4,6-10,18H,3,5H2,(H,22,25)(H,23,26)
Standard InChI Key: MWCKXDDCNSVXSP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
34.2285 -6.7315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9412 -6.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9412 -5.4970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2285 -5.0800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2289 -4.2550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9458 -3.8427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9461 -3.0177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2304 -2.6039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5128 -3.0213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5161 -3.8449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5158 -6.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5158 -5.4925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7260 -5.2358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2380 -5.9076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7260 -6.5793 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.6576 -5.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3715 -5.5011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6600 -4.2604 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.0879 -5.0904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7985 -5.5089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5144 -5.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5173 -4.2721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7983 -3.8573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0854 -4.2698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2282 -5.5142 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
37.7978 -3.0315 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
34.2293 -1.7781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12 4 1 0
11 1 1 0
1 2 1 0
2 3 1 0
3 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 5 2 0
4 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
3 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
21 25 1 0
23 26 1 0
8 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 420.32Molecular Weight (Monoisotopic): 419.0262AlogP: 4.92#Rotatable Bonds: 2Polar Surface Area: 65.20Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.97CX Basic pKa: ┄CX LogP: 3.77CX LogD: 3.77Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.62Np Likeness Score: -1.71
References 1. Wortmann L, Lindenthal B, Muhn P, Walter A, Nubbemeyer R, Heldmann D, Sobek L, Morandi F, Schrey AK, Moosmayer D, Günther J, Kuhnke J, Koppitz M, Lücking U, Röhn U, Schäfer M, Nowak-Reppel K, Kühne R, Weinmann H, Langer G.. (2019) Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo., 62 (22): [PMID:31670515 ] [10.1021/acs.jmedchem.9b01382 ]